chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CHILLS; FEVER; BURNING SKIN; HOT FLASHES/FEELING HOT; FATIGUE; This spontaneous report received from a patient concerned a 40 year old male. The patient's weight was 77.1 kilograms, and height was 175.26 centimeters. The patient's concurrent conditions included seasonal allergy, alcohol use, and non smoker, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient was previously treated with diphtheria vaccine toxoid/pertussis vaccine acellular/ toxoid for prophylactic vaccination; and experienced reactions to vaccines when treated with diphtheria vaccine toxoid/pertussis vaccine acellular/tetanus vaccine toxoid, and tetanus vaccine for prophylactic vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808609 expiry: 09-JUN-2021) dose was not reported, administered on 19-MAR-2021 14:00 in the right arm for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced hot flashes/feeling hot. On MAR-2021, the subject experienced fatigue. On 19-MAR-2021, the subject experienced burning skin. On 19-MAR-2021 22:00, the subject experienced chills. On 19-MAR-2021 22:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning skin, hot flashes/feeling hot, chills, fever, and fatigue on 20-MAR-2021. This report was non-serious.  Additional information was received from the patient on 30-MAR-2021. Following information was updated into the case: other identification numbers added, patient's contact details added (address, city, zip code, email address and phone number), patient demographics added (age ,age group, gender, height, and weight), concurrent condition added ( seasonal allergy, non-smoker, alcoholic), event added (fatigue and hot flashes/feeling hot), past reaction added( reactions to vaccines), suspect drug route of administration added ((intramuscular), vaccination time added, past drug added (Tetanus and TDAP) and due diligence updated.
This spontaneous report was received from a certified medical assistant concerning a patient of unknown age and gender. On 15-NOV-2012, the patient was vaccinated with the first dose of 0.5 milliliter (ml) of GARDASIL (lot number and expiry date unspecified), intramuscularly. On 24-JAN-2013, the patient was vaccinated with the second dose of 0.5 ml of GARDASIL (lot number and expiry date unspecified), intramuscularly. On 22-MAR-2013 (about 5 weeks early), the patient was vaccinated with the third dose of 0.5 ml of GARDASIL (lot number and expiry date unspecified), intramuscularly. No concomitant medications were reported. No adverse effect was reported. Additional information has been requested.
Patient experienced dyspnea on exertion and lightheadedness shortly after receiving vaccine. He continued with these symptoms until presenting to ER on 6/6/2021 and found to have extensive bilateral pulmonary emboli.
Extreme  menstrual irregularities, including:  losing pints of blood and large blood clots over the course of a day or two; bleeding (not spotting) for weeks without end; irregular menstrual cycles (I have always been extremely regular).
stool had a weird strong odor; urine had a weird strong odor; induration at injection site; Itchy at injection site; swollen at the injection site; sore at the injection site; red at injection site; fatigue; headache; This spontaneous case was reported by a nurse and describes the occurrence of ABNORMAL FAECES (stool had a weird strong odor), URINE ODOUR ABNORMAL (urine had a weird strong odor), INJECTION SITE INDURATION (induration at injection site), INJECTION SITE PRURITUS (Itchy at injection site) and INJECTION SITE SWELLING (swollen at the injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asymptomatic COVID-19 in September 2020.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced INJECTION SITE INDURATION (induration at injection site), INJECTION SITE PRURITUS (Itchy at injection site), INJECTION SITE SWELLING (swollen at the injection site), INJECTION SITE PAIN (sore at the injection site), INJECTION SITE ERYTHEMA (red at injection site), FATIGUE (fatigue) and HEADACHE (headache). On 28-Feb-2021, the patient experienced ABNORMAL FAECES (stool had a weird strong odor) and URINE ODOUR ABNORMAL (urine had a weird strong odor). On 01-Mar-2021, INJECTION SITE INDURATION (induration at injection site), INJECTION SITE PRURITUS (Itchy at injection site), INJECTION SITE SWELLING (swollen at the injection site), INJECTION SITE PAIN (sore at the injection site), INJECTION SITE ERYTHEMA (red at injection site), FATIGUE (fatigue) and HEADACHE (headache) had resolved. At the time of the report, ABNORMAL FAECES (stool had a weird strong odor) and URINE ODOUR ABNORMAL (urine had a weird strong odor) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2020, SARS-CoV-2 antibody test positive: positve (Positive) Positive by IgG antibody test. In January 2021, SARS-CoV-2 antibody test positive: negative (Negative) Negative by IgG antibody test.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  The patient reported that she had not eaten anything new or taken any new medication since the vaccine. Treatment for headache, fatigue, and swollen, induration, sore, itchy, and red at injection site included paracetamol and ice at the injection site.   Reporter did not allow further contact
Almost feels like a head rush that doesn't go away; "spells" of EXTREME exhaustion and body aches that come and go since; got my vaccine on Friday and have been having "spells" of EXTREME exhaustion and body aches that come and go since; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Almost feels like a head rush that doesn't go away), FATIGUE ("spells" of EXTREME exhaustion and body aches that come and go since) and MYALGIA (got my vaccine on Friday and have been having "spells" of EXTREME exhaustion and body aches that come and go since) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (Almost feels like a head rush that doesn't go away), FATIGUE ("spells" of EXTREME exhaustion and body aches that come and go since) and MYALGIA (got my vaccine on Friday and have been having "spells" of EXTREME exhaustion and body aches that come and go since). At the time of the report, HEAD DISCOMFORT (Almost feels like a head rush that doesn't go away), FATIGUE ("spells" of EXTREME exhaustion and body aches that come and go since) and MYALGIA (got my vaccine on Friday and have been having "spells" of EXTREME exhaustion and body aches that come and go since) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Followup case
This spontaneous report was received from a Medical Assistant concerning an unspecified number of patients of an unknown age and gender. The patients' concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with an improperly stored doses of M-M-R II (lot number L036851, expiration date 23-SEP-2017, lot number M008588 expiration date 16-FEB-2018, dose and route were not reported) for prophylaxis. The temperature excursion was between 46° F and 77° F for 2 hours and 54 minutes, and between 32° F and 36° F for 17 hours and 42 minutes. It was reported that there was additional excursions but the reporter did not have details. There was no previous excursions involved and a data logger was related. A product qulaity complaint was not involved. Additional information has been requested. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1702USA002297:Original Case : 1702USA002297.
I know other people who had recent flu vaccine at pharmacy and they are reporting the same adverse reaction.  I don't think it was the flu or a cold.  But it has lingered and I feel poisoned is the best way to describe it.  The symptoms are high fever, exhaustion, pain, weakness and sinus congestion.  For me it didn't result in coughing like flu normally does.  It didn't produce any mucus either as flu normally does.  Maybe you should have the vaccinetested given all of the problems recently with tainted medications being imported.
This spontaneous report as received from a healthcare worker and a nurse refers to unspecified number of patients. Medical history and concomitant medications were unknown. It was reported that, improperly stored doses of PNEUMOVAX 23 (single dose vials, route of administrations, doses, lot numbers and expiry dates were not reported) were given to unspecified patients on unspecified dates. No adverse experience was reported. No product quality complaint (PQC) was involved. Follow up has been received from a healthcare worker on 06-JUL-2015: It was reported that on 26-FEB-2014, the patient of unknown age and gender was vaccinated with improperly stored PNEUMOVAX 23 (Lot number: J010654, Expiry date: 17-OCT-2014). This is one of several reports from the same reporter. Additional information has been requested.
Feeling hot and feeling tingling and numbing of lips and tongue for about 10 minutes.  This abated and felt fine for over 10 hours.  Then at about 9:30 PM, starting to feel chilled.  Took warm shower and went to bed, but began shivering, and heart rate increased. Blood pressure and pulse checked with fairly new electronic home unit (Omron HEM 780): @10:30 PM - 144/94, 100b/m @10:48 PM - 134/89, 101b/m @11:22 PM - ------,  94b/m Shivering continued for about 2 hr, but with decreasing intensity. Slept poorly and felt very tired with sore muscles until about 2 PM.  Felt pretty normal around 6 PM after eating a complete dinner.
Large, localized red, swollen area left thigh laterally.  Blanches with pressure.  No tenderness with few tiny papules.
Client visited health department on Thursday - March 4th 2010 and spoke with my supervisor c/o that his entire family including himself has had chest congestion, runny nose, aches, on and off fever since receiving the H1N1 vaccine. Client states he was not seen by a medical physician regarding above signs and symptoms.
Painful lymph glands in neck for more that 2 weeks; Profuse sweating every night for more than 2 weeks; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female (non pregnant) patient received first dose of BNT162B2 (Covid shot, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown, Expiry date: Unknown) via an unspecified route of administration at left arm on 13Jan2021 02:00 PM as single dose for COVID-19 immunization. Patient did not receive any other vaccine in four weeks. The patient medical history was not reported. There was no known allergies. The concomitant medications of patient included ibuprofen (IBUPROFEN) (other medications in two weeks). On 31Jan2021 17:00, the patient experienced painful lymph glands in neck, profuse sweating every night. Patient stated adverse event as painful lymph glands in neck for more that 2 weeks. Profuse sweating every night for more than 2 weeks. There was no covid prior vaccination and no covid tested post vaccination. Treatment of event was unknown. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected. Information on lot and batch numbers cannot be obtained.
23Feb98 pt rrcv_ vax. Within 1 hr pt devel disseminated hives.
24 hours after typhoid vaccination pt states he developed slight sore throat and "stuffed up head". Sore throat went away in a few days but "stuffed up head" continues, mostly at night. Denies other sx's.
Patient  came in for his second shot of Moderna vaccine, deny all prevaccination assessment questions but confirm his first dose of vaccine was also Moderna. After the assessment was done and consent was confirmed. The vaccine was given in the patient?s right deltoid. However,  the injection only had 0.02 to 0..03 ml of vaccine in the syringe so another full dose of 0.5 ml was immediately given in the same arm. the patient had no side effects, no immediate adverse all logic reactions. Then left the facility in a hurry despite all attempts from several staff for patient to stay for 15 minutes observation.
One day after shot experienced extreme stiffness in my ankle which I had sprained several times. Felt stiff and swollen and mobility in ankle  was not normal.  Overall muscle fatigue Ankle stiffness  continued for 3-4 days overall muscle fatigue for more like 6 weeks 3-4 days after injection I had nerve pain that radiated down my thighs occassionally and would last for only a few seconds. But persisted on and off. Also experienced same pain running up my calves from time to time. After about a week I went to an urgent care and then the ER after a panic attack. Then in the end went to my family nurse practinioner. Muscle weakness and shooting nerve pains went on for 6 weeks resulting in anxiety issues as I did not know what was coming next. Most of the other symptoms I experienced after these initial effects I believe were mostly the anxiety.  After 6 weeks the shooting nerve pains went away Several months later now in Nov/Dec I have congested ear feeling, sinus issues. The ears also ring from time to time and my right ear also has an eardrum that vibrates The DR gave me antibiotics because I had fluid in ear in Late NOv but the fullness of right ear never went away.. the vibration did go away but it came back in late December with more ringing ears and continued stuffiness.
Information has been received from a physician concerning a 18 year old male who on 10-JUN-1992 was vaccinated with the first dose of RECOMBIVAX HB (lot # 602638/0310V) into the left thigh. On 02-JUL-1992, the patient received the second dose of RECOMBIVAX HB and on 23-MAR-1993, the patient received a third dose of hepatitis B virus vaccine (unspecified) (lot # 1094A2). Concomitant therapy included ORIMUNE (lot # 320-932). Per serum hepatitis B surface antibody screen done on 29-JUL-2010, the patient was no longer immune. Result was 0.23, inconsistent with immunity. At the time of the report, the outcome of the patient was unknown. Additional information has been requested.
Very large lump occured at injection site, now 2 months later and dr. can still feel small lump. Nurse said must have been an abcess.
Couldn't move.  Body aches, headache, sick to stomach.  On a scale of 1-10, my experience was about an 8:10 in aches, pain, couldn't move, couldn't sleep.  This lasted for 48 hours and began 12 hours after receiving the 1st shot.
Information has been received from a physician concerning second and third graders who were vaccinated with varicella virus vaccine live (Oka/Merck). Subsequently, there was chickenpox "outbreak" in an elementary school. The physician was unsure how many children had previous been vaccinated. Further information has been received from the office manager in the physicians office. It was reported that there was only one patient who had chickenpox and that was a 13 year old male. It was reported she had no idea how many patients were involved in the outbreak. Additional information has been requested.
sore arm; This is a spontaneous report from a contactable consumer (patient). A 57-years-old female (not pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left at age of 57 years on 18Jul2021 15:00 (Lot Number: EW0178) as dose 1, single for covid-19 immunisation. Medical history included took meds for diabetes. The patient's concomitant medications were not reported. No other vaccine in four weeks. The patient previously allergy to Codeine.  After the first shot, patient had a sore arm but there was no bump like there was after the second shot. Patient did not have more than sore arm after first shot. No COVID prior vaccination, no COVID tested post vaccination. Unknown if treatment was received. The patient hadn't go to a doctor because she didn't know if this was normal or not. The outcome of the event was unknown.
Fever 100 F Severe body aches  Migraine type of headache  Nausea and diarrhea  All lasting 16 hours Still slight headache
Client complained of stomach hurting and throat "feeling thick".  BP 112/80, No itching or sneezing.  Unable to take any fluids. Client given .35 epinephrine IM BP 118/82 O2 placed on client.  Client then sneezed one time.  .7 benadryl given IM and EMS was called
Pregnant: approximately 37 wks 3 days  Due Date: August 11th  Injection given. Approximately 15-30 seconds passed. Feeling that something was wrong, lasted only a second before I felt like my breathing was changing. Felt a pressure on all sides of me, heaviness. Each breath became harder to take. Called for help. Tried to stand but could not, fell to floor. Very difficult to get in air at all. Crawled into room with technician who went for emergency supplies. Could not breath. Technician tried to administer one epi-pen, which failed to work. Administered a second. Within 5-10 seconds breathing began to improve. I began to shake uncontrollably. Chest pain /pressure started in center of chest. Unable to move from side of sit up without breathing suffering. I was taken by emergency services to the nearest hospital to make sure breathing/oxygen levels were stable. Taken to Hospital. Contractions started after about 15-20 minutes in the ambulance. The ER ran tests/labwork. I'm unaware of what they are. Once I was deemed stable for transfer, with contractions continuing, I was was transferred to Medical Center to be monitored at Labor and Delivery for potential early labor. I was discharged that evening when labor did not progress.
p/vax 1 1/2hr later eyes became bloodshot & started hurting;exp bodyaches & a sore throat & could hardly swallow;
PRESSURE IN HEAD; DIZZINESS; MUSCLE WEAKNESS (JUST FEELING EXHAUSTED WHEN HE STANDS); POUNDING HEADACHE; TEMPERATURE (100.6 F); This spontaneous report received from a patient concerned a 37 year old male. The patient's height, and weight were not reported. The patient's past medical history included: migraines, and heart murmur, and concurrent conditions included: shellfish allergy, iodine allergy, alcohol user, and non smoker, and other pre-existing medical conditions included: The patient did not have any history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry: 20-MAR-2022) dose was not reported, administered on 03-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-NOV-2021, the patient experienced pressure in head, dizziness, muscle weakness (just feeling exhausted when he stands), pounding headache, and temperature (100.6 f). Laboratory data included: Body temperature (NR: not provided) 100.6 F. On 04-NOV-2021, Laboratory data included: Body temperature (NR: not provided) 99.9 F. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pounding headache, pressure in head, dizziness, temperature (100.6 f), and muscle weakness (just feeling exhausted when he stands). This report was non-serious.
patient had shingles with a rash on her back/itching; This spontaneous case was reported by a patient and describes the occurrence of HERPES ZOSTER (patient had shingles with a rash on her back/itching) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Atrial fibrillation and Congestive heart failure. Concomitant products included FUROSEMIDE (LASIX [FUROSEMIDE]) for Atrial fibrillation and Congestive heart failure.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (patient had shingles with a rash on her back/itching). At the time of the report, HERPES ZOSTER (patient had shingles with a rash on her back/itching) outcome was unknown.            The most recent monovalent vaccine occurred 6 month ago. She used a cream as a treatment medication to help with the itching.   Reporter did not allow further contact
Mother states that pt's right upper arm "red, swollen and warm to touch." Office appt on 2/16/2000, was afebrile, no limited movement of arm, no spreading cellulitis. Treat with ice for 24 hours then warm compresses and take Advil.
Fatigue , confusion for 24-48hrs after, random shooting pains, numbness at corner of mouth
Patient stated that she is on gilenya for MS; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on Mar2021 as Dose 2,Single and dose 1 via an unspecified route of administration on Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. Medical history included multiple sclerosis from an unknown date and unknown if ongoing. Concomitant medication(s) included fingolimod hydrochloride (GILENYA) taken for multiple sclerosis, start and stop date were not reported. The patient experienced antibody tests performed prior at a research clinic for ucsf, all came back negative for antibody (medically significant) on an unspecified. Patient stated that she is on gilenya for MS which research has shown affect the Pfizer vaccine effectiveness, because it is a an Immunosuppressive drug. She us a in a research at UCSF. I am afraid that the only way for me to get protection is to get off gilenya for 60 days and then get the vaccine again, and than get back on the gilenya, which when you been off it that long it take s all kinds of heart studies to get back on the drug again. Besides the fact that there are multiple reports of cases of people who go off that drug, and do not go immediately on another drug, there are increase exacerbation of MS, and 35 cases in the last 8 years, people have gone from being mobile and living a normal life to being in a wheelchair after who come off gilenya, within 12 weeks. The patient underwent lab tests and procedures which included antibody test: negative. The outcome of the event was unknown  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt did not respond p/series of 3 inject of Hep B vax.  3rd vax given 12NOV90; Reported not immune to Hep B.